We are live on ! Find out more
PM

Penbrook Management Portfolio holdings

AUM $157M
1-Year Est. Return 46.57%
This Fund
S&P 500
This Quarter Est. Return
+40.87%
1 Year Est. Return
+46.57%
3 Year Est. Return
+102.93%
5 Year Est. Return
+150.44%
10 Year Est. Return
–
AUM
$102M
AUM Growth
+$23.6M
Cap. Flow
+$708K
Cap. Flow %
0.7%
Top 10 Hldgs %
41.2%
Holding
109
New
6
Increased
19
Reduced
18
Closed
6

Top Buys

Rank Stock Value
1
VICR icon
Vicor
VICR
+$505K
2
AZTA icon
Azenta
AZTA
+$498K
3
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
+$434K
4
USAC icon
USA Compression Partners
USAC
+$374K
5
INVE icon
Identive
INVE
+$261K

Top Sells

Rank Stock Value
1
CYRX icon
CryoPort
CYRX
+$631K
2
CYBE
Cyberoptics Corp
CYBE
+$575K
3
AGN
Allergan plc
AGN
+$511K
4
FIS icon
Fidelity National Information Services
FIS
+$234K
5
ACLS icon
Axcelis
ACLS
+$219K

Sector Composition

Rank Sector Weight
1 Technology 27.71%
2 Healthcare 17.53%
3 Financials 10.01%
4 Consumer Discretionary 9.62%
5 Industrials 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADP icon
26
Automatic Data Processing
ADP
$107B
$1.14M 1.12%
7,628
– –
CSCO icon
27
Cisco
CSCO
$457B
$1.1M 1.08%
23,500
– –
NNY icon
28
Nuveen New York Municipal Value Fund
NNY
$155M
$1.07M 1.05%
110,000
– –
DAIO icon
29
Data I/O
DAIO
$30.4M
$1.04M 1.02%
307,610
+5,600
+2% +$17.5K
FISV
30
Fiserv Inc
FISV
$29B
$983K 0.97%
10,068
-800
-7% -$80.6K
USAC icon
31
USA Compression Partners
USAC
$3.73B
$961K 0.95%
88,525
+37,885
+75% +$374K
SA
32
Seabridge Gold
SA
$2.84B
$887K 0.87%
50,580
– –
BKI
33
DELISTED
Black Knight, Inc. Common Stock
BKI
$865K 0.85%
11,918
– –
BPOP icon
34
Popular Inc
BPOP
$11.1B
$860K 0.85%
23,145
+525
+2% +$19.6K
KOPN icon
35
Kopin
KOPN
$693M
$838K 0.82%
630,130
– –
INVE icon
36
Identive
INVE
$64.8M
$783K 0.77%
153,577
+66,032
+75% +$261K
POWI icon
37
Power Integrations
POWI
$3.37B
$780K 0.77%
13,200
– –
HMSY
38
DELISTED
HMS Holdings Corp.
HMSY
$768K 0.76%
23,700
-250
-1% -$7.24K
BRK.B icon
39
Berkshire Hathaway Class B
BRK.B
$1.11T
$759K 0.75%
4,250
– –
CVS icon
40
CVS Health
CVS
$134B
$759K 0.75%
11,680
+380
+3% +$23.9K
BLFS icon
41
BioLife Solutions
BLFS
$1.57B
$752K 0.74%
45,995
– –
CEMI
42
DELISTED
Chembio diagnostics, Inc.
CEMI
$722K 0.71%
222,220
+24,660
+12% +$234K
SYF icon
43
Synchrony
SYF
$25.3B
$690K 0.68%
31,150
+2,000
+7% +$39K
NVGS icon
44
Navigator Holdings
NVGS
$1.35B
$671K 0.66%
104,350
+3,000
+3% +$18.8K
ABBV icon
45
AbbVie
ABBV
$433B
$667K 0.66%
6,794
+2,894
+74% +$255K
VICR icon
46
Vicor
VICR
$9.85B
$648K 0.64%
+9,000
New +$505K
IVAC
47
DELISTED
Intevac Inc
IVAC
$634K 0.62%
116,120
– –
BDX icon
48
Becton Dickinson
BDX
$46.9B
$625K 0.61%
2,679
-321
-11% -$77.4K
IMMR icon
49
Immersion
IMMR
$248M
$610K 0.6%
98,020
-1,120
-1% -$7.23K
TWOU
50
DELISTED
2U Inc
TWOU
$607K 0.6%
533
– –
1
2
3 4 5

Similar funds

IWM
IMG Wealth Management Jacksonville, Florida $157M AUM 17.95% 1-Year Est. Return
EP
Elkhorn Partners Omaha, Nebraska $157M AUM 11.91% 1-Year Est. Return
AC
AlpenGlobal Capital Tahoe City, California $157M AUM
SF
Seros Financial Tempe, Arizona $157M AUM 16.95% 1-Year Est. Return
LAM
Lakewood Asset Management Naperville, Illinois $156M AUM 15.91% 1-Year Est. Return
HAM
Harber Asset Management Asheville, North Carolina $156M AUM 2.37% 1-Year Est. Return
HEM
Henson-Edgewater Management Avon, Ohio $157M AUM
CF
CDC Financial Chicago, Illinois $157M AUM

Penbrook Management's Q2 2020 Portfolio in Review

As of Q2 2020, Penbrook Management held 109 positions worth $102M, up 30% from $78.1M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Penbrook Management's Q2 2020 filing shows 6 new, 19 increased, 18 reduced and 6 closed positions. Its largest new stake was Vicor: 9,000 shares worth $648K. The largest sale was CryoPort, an estimated $631K.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Penbrook Management's largest Q2 2020 buy was Vicor: 9,000 shares worth $648K.
  • Penbrook Management added most to Azenta in Q2 2020, an estimated $498K increase.
  • Penbrook Management's biggest Q2 2020 reduction was CryoPort, cutting an estimated $631K.
  • Penbrook Management fully exited Allergan plc in Q2 2020, selling an estimated $511K.
  • Penbrook Management's ten largest holdings make up 41% of its $102M portfolio in Q2 2020.
  • Penbrook Management opened 6 new positions and closed 6 in Q2 2020.
  • Penbrook Management's portfolio value rose 30% quarter-over-quarter to $102M.

Based on Penbrook Management's 13F filing for Q2 2020, filed 28 Jul 2020.